Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis-Reference-Cited by-同舟云学术

Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis

Published:2017-04-04 Issue:7 Volume:47 Page:909-917
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Gülen T.¹²³⁴^ORCID,Möller Westerberg C.¹,Lyberg K.¹,Ekoff M.¹,Kolmert J.⁵,Bood J.⁵,Öhd J.⁶,James A.⁴⁵,Dahlén S.-E.⁴⁵,Nilsson G.¹³⁴,Dahlén B.³⁴⁷

Affiliation:

1. Department of Medicine, Clinical Immunology and Allergy Research Unit; Karolinska University Hospital Solna, Karolinska Institutet; Stockholm Sweden

2. Department of Respiratory Medicine and Allergy; Karolinska University Hospital Huddinge; Stockholm Sweden

3. Mastocytosis Centre Karolinska; Karolinska University Hospital and Karolinska Institutet; Stockholm Sweden

4. Centre for Allergy research (CfA); Karolinska Institutet; Stockholm Sweden

5. Department of Environmental Medicine, Experimental Asthma and Allergy Research; Karolinska Institutet; Stockholm Sweden

6. Department of Clinical R&D; Medivir AB; Huddinge Sweden

7. Department of Medicine Huddinge; Karolinska Institutet; Stockholm Sweden

Funder

Vetenskapsrådet

Cancerfonden

Karolinska Institutet

Stockholms Läns Landsting

Hjärt-Lungfonden

Cancer and Allergy Foundation

Konsul TH C Bergh Foundation

ChAMP project

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.12914/fullpdf

Reference25 articles.

1. Mast cell mediators in allergic inflammation and mastocytosis;Castells;Immunol Allergy Clin North Am,2006

2. Differential release of mast cell mediators and the pathogenesis of inflammation;Theoharides;Immunol Rev,2007

3. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria;Valent;Eur J Clin Invest,2007

4. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience;Gulen;Clin Exp Allergy,2014

5. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis;Schwartz;N Engl J Med,1987

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using the Right Criteria for MCAS;Current Allergy and Asthma Reports;2024-01-20

2. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis;Immunology and Allergy Clinics of North America;2023-11

3. A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis;Diagnostics;2023-10-25

4. Triggers of Anaphylaxis in Mastocytosis Patients: Evidence of the Current Drug-Avoidance Recommendation;Current Treatment Options in Allergy;2023-09-20

5. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium;The Journal of Allergy and Clinical Immunology: In Practice;2022-08